Kobo Biotech Limited (BOM:531541)
India · Delayed Price · Currency is INR 9.45
+0.18 (1.94%)
At close: Jul 14, 2026
Kobo Biotech Statistics
Total Valuation
Kobo Biotech has a market cap or net worth of INR 225.15 million. The enterprise value is 1.58 billion.
| Market Cap | 225.15M |
| Enterprise Value | 1.58B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kobo Biotech has 23.83 million shares outstanding.
| Current Share Class | 23.83M |
| Shares Outstanding | 23.83M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 2.16% |
| Owned by Institutions (%) | n/a |
| Float | 12.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.39 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -51,312.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.49% |
| Return on Invested Capital (ROIC) | -76.98% |
| Return on Capital Employed (ROCE) | 5.05% |
| Weighted Average Cost of Capital (WACC) | 0.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -108,054 |
| Employee Count | 484 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +243.64% in the last 52 weeks. The beta is 0.44, so Kobo Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +243.64% |
| 50-Day Moving Average | 5.46 |
| 200-Day Moving Average | 3.22 |
| Relative Strength Index (RSI) | 98.54 |
| Average Volume (20 Days) | 74,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -4,000 |
| Operating Income | -51.31M |
| Pretax Income | -52.30M |
| Net Income | -52.30M |
| EBITDA | -10.68M |
| EBIT | -51.31M |
| Earnings Per Share (EPS) | -2.20 |
Balance Sheet
The company has 43.56 million in cash and 1.40 billion in debt, with a net cash position of -1.35 billion or -56.80 per share.
| Cash & Cash Equivalents | 43.56M |
| Total Debt | 1.40B |
| Net Cash | -1.35B |
| Net Cash Per Share | -56.80 |
| Equity (Book Value) | -1.38B |
| Book Value Per Share | -57.98 |
| Working Capital | -1.31B |
Cash Flow
| Operating Cash Flow | 41.75M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 40.63M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Kobo Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | 0.31% |
| Earnings Yield | -23.23% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |